Inspire Medical Systems, Inc. (INSP) Q4 2024 Earnings Call Transcript

Inspire Medical Systems, Inc. (NYSE:INSP) Q4 2024 Earnings Conference Call February 10, 2025 5:00 PM ET

Company Participants

Ezgi Yagci – Vice President of Investor Relations
Tim Herbert – President & Chief Executive Officer
Rick Buchholz – Chief Financial Officer

Conference Call Participants

Travis Steed – Bank of America Securities
Danielle Antalffy – UBS
Robbie Marcus – JPMorgan
Chris Pasquale – Nephron Research
Anthony Petrone – Mizuho Financial Group
Richard Newitter – Truist Securities
David Rescott – Baird
Adam Maeder – Piper Sandler
Larry Biegelsen – Wells Fargo
Shagun Singh – RBC Capital Markets
Brett Fishbin – KeyBanc Capital Markets
Jon Block – Stifel
Michael Polark – Wolfe Research
Mike Kratky – Leerink Partners
Suraj Kalia – Oppenheimer & Co.

Operator

Good afternoon. My name is Dilem [ph] and I’ll be your conference operator today. At this time, I would like to welcome everyone to the Inspire Medical Systems Fourth Quarter and Full Year 2024 Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session.

I’ll now hand the call over to your first speaker, Ezgi Yagci, the Vice President of Investor Relations at Inspire. You may begin the conference.

Ezgi Yagci

Thank you, Dilem [ph] and thank you all for participating in today’s call. Joining me are Tim Herbert, Chairman and Chief Executive Officer; and Rick Buchholz, Chief Financial Officer.

Earlier today, we released financial results for the 3 and 12 months ended December 31, 2024. A copy of the press release is available on our website. On this call, management will make forward-looking statements within the meaning of the federal securities laws. All forward-looking statements, including, without limitation, those relating to our operations, financial results and financial condition, investments in our business, full year 2025 financial and operational outlook and changes in market access, are based upon